Fundamental dimension Equity attribute | FCFLeader $21.10▲+0.19% Cap $2.13BP/E 12.9x QuantScore64/100 | BLXPeer $53.91▼-2.65% Cap $1.55BP/E 8.9x QuantScore51/100 | CCBPeer $45.22▲+0.71% Cap $691.2MP/E -180.9x QuantScore64/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
94/100 |
57/100 |
72/100 |
Valuation Multiples, PEG & DCF upside | 91/100 | 74/100 | 72/100 |
Health Piotroski, Altman Z, leverage & liquidity | 36/100 | 33/100 | 50/100 |
Growth Revenue / earnings growth & margins | 40/100 | 28/100 | 47/100 |
Sentiment Analyst ratings, targets & revisions | 58/100 | 61/100 | 78/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 12.9x | 8.9x | -180.9x |
Forward P/E (next FY) | 12.2x | 8.5x | 36.9x |
EV / EBITDA (TTM) | 18.4x | 17.5x | 7.4x |
Price / Sales | 3.4x | 2.6x | 0.9x |
Price / Free Cash Flow | 11.9x | 4.0x | 2.6x |
PEG ratio | 0.49 | 5.90 | 1.68 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 6 / 9 | 5 / 9 |
Altman Z-Score | -0.52 (Distress) | 0.39 (Distress) | 1.23 (Distress) |
Total debt / equity | 0.17 | 2.53 | 0.11 |
Quick ratio | 0.2x | 6.9x | 898.6x |
Interest coverage | 0.6x | 0.4x | 0.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +4.3% | -58.1% | +14.7% |
Net income growth YoY | +6.8% | +10.2% | +3.9% |
Gross margin (TTM) | 62.8% | 54.2% | 53.6% |
Operating margin (FY) | 27.2% | 66.8% | 9.3% |
FCF margin (FY) | 23.5% | 109.2% | 37.2% |
5. Trailing price performancePrice change over period |
1M return | +0.9% | -1.5% | +0.9% |
3M return | +1.1% | -9.6% | -37.4% |
6M return | +13.3% | -4.6% | -45.0% |
Year to date | +25.1% | +20.9% | -60.5% |
1Y return | +29.4% | +19.2% | -57.6% |
3Y return | +82.7% | +153.9% | +14.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $25.83 +22.4% upside | $94.26 +74.8% upside | $251.67 +456.5% upside |
Wall Street consensus target | $30.00 +42.2% · range $24.00–$48.00 | — — | $69.00 +52.6% · range $47.00–$110.00 |
Consensus stance | 44% Buy56% Hold0% Sell | 67% Buy0% Hold33% Sell | 80% Buy20% Hold0% Sell |